I've been in tis since the ipo, it did run to just over $1 shortly after the float. It sounded like a great product but it's been a long haul to get to this point, typical biotech. I thought of bailing a few times but luckily averaged down to 11c. I'm glad to in it now but, I don't feel too clever about it, probably could have done much better elsewhere. Great going anyone who has bought in recently.
